Shield Therapeutics plc (AIM:STX)

Shield Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	32.18	13.09	5.5	2.06	14.18
Revenue	32.18	13.09	5.5	2.06	14.18
Revenue Growth (YoY)	145.93%	137.95%	167.36%	-85.50%	1389.24%
Cost of Revenue	17.25	9.06	3.04	1.33	1.85
Gross Profit	14.93	4.03	2.46	0.73	12.33
Selling, General & Admin	36.01	37.96	33.65	27.28	11.75
Research & Development	1.89	1.81	1.32	1.08	3.52
Other Operating Expenses	-0.1	-4.41	-0.86	-0.15	-
Operating Expenses	37.8	35.36	34.1	28.21	15.27
Operating Income	-22.87	-31.33	-31.65	-27.48	-2.94
Interest Expense	-3.87	-1.02	-0.4	-	-
Interest & Investment Income	0.27	0.52	0.04	0.02	0
Currency Exchange Gain (Loss)	-0.08	-0.54	0.85	0.52	0.36
Other Non Operating Income (Expenses)	-	-0	-0.08	-0.01	-0
EBT Excluding Unusual Items	-26.56	-32.38	-31.24	-26.96	-2.57
Asset Writedown	-	-	-18.11	-	-
Pretax Income	-26.56	-32.38	-49.34	-26.96	-2.57
Income Tax Expense	0.63	0.92	0.45	-0.31	1.02
Earnings From Continuing Operations	-27.18	-33.29	-49.79	-26.65	-3.59
Net Income	-27.18	-33.29	-49.79	-26.65	-3.59
Net Income to Common	-27.18	-33.29	-49.79	-26.65	-3.59
Shares Outstanding (Basic)	783	723	233	204	117
Shares Outstanding (Diluted)	783	723	233	204	117
Shares Change (YoY)	8.33%	209.85%	14.08%	74.36%	0.21%
EPS (Basic)	-0.03	-0.05	-0.21	-0.13	-0.03
EPS (Diluted)	-0.03	-0.05	-0.21	-0.13	-0.03
Free Cash Flow	-6.81	-37.37	-22.66	-25.23	-1.91
Free Cash Flow Per Share	-0.01	-0.05	-0.10	-0.12	-0.02
Gross Margin	46.39%	30.78%	44.70%	35.48%	86.96%
Operating Margin	-71.08%	-239.44%	-575.49%	-1336.01%	-20.74%
Profit Margin	-84.47%	-254.44%	-905.42%	-1295.46%	-25.32%
Free Cash Flow Margin	-21.15%	-285.56%	-411.98%	-1226.73%	-13.48%
EBITDA	-22.38	-31.08	-29.67	-25.39	0.03
EBITDA Margin	-69.56%	-237.51%	-	-	0.23%
D&A For EBITDA	0.49	0.25	1.97	2.09	2.97
EBIT	-22.87	-31.33	-31.65	-27.48	-2.94
EBIT Margin	-71.08%	-239.44%	-	-	-20.74%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.